In:
Cancer, Wiley, Vol. 118, No. 22 ( 2012-11-15), p. 5518-5524
Abstract:
In this survey of primary care providers, the majority of respondents (59.3%) take both age and life expectancy into account in deciding when to discontinue prostate‐specific antigen‐based prostate cancer screening. However, providers report difficulty assessing life expectancy and multiple barriers to discontinuing screening.
Type of Medium:
Online Resource
ISSN:
0008-543X
,
1097-0142
DOI:
10.1002/cncr.v118.22
Language:
English
Publisher:
Wiley
Publication Date:
2012
detail.hit.zdb_id:
1479932-7
detail.hit.zdb_id:
2599218-1
detail.hit.zdb_id:
2594979-2
detail.hit.zdb_id:
1429-1